Skip to content

Enhancing Inhibition With tDCS in Low Back Pain

Enhancing Inhibition With tDCS in Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03864822
Enrollment
12
Registered
2019-03-06
Start date
2019-04-29
Completion date
2020-10-07
Last updated
2020-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

This cross-over study intends to use consecutive days of active versus sham transcranial direct current stimulation (tDCS) to enhance descending inhibition and look at resulting clinical effects in people with low back pain.

Interventions

Device uses an array of electrodes over the scalp, in contact via gel, to provide a weak electrical current.

Sponsors

Danish National Research Foundation
CollaboratorOTHER
Aalborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Stimulation type will be randomized by a colleague not involved in the study. A single investigator will assess all outcomes on all participants before and after each phase of stimulation, but participants not the investigator will be aware of Active/Sham assignment until after study completion

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Otherwise healthy men and women * Aged 18-60 years * Continuous pain (\>3days pain/week) episode lasting at least 3 months, sufficient to limit daily activities * Pain in the region posteriorly between the inferior border of the 12th rib and the lower gluteal fold (low back pain) at the time of recruitment * Able to speak, read and understand English

Exclusion criteria

* Pregnancy * Low back pain associated with menstruation * Currently seeking active treatment for low back pain * Red flags symptoms (i.e. fever, malaise, progressive neurologic deficit, significant trauma, prolonged corticosteroid use or osteoporosis, pain worst at night, urinary or faecal incontinence, or unintended weight loss) * Drug addiction defined as the use of cannabis, opioids or other drugs * Current or previous neurologic, musculoskeletal, mental, or other illnesses which may affect the trial * Current or previous chronic or recurrent pain condition other than low back pain * Current regular use of analgesic medication or other medication which may affect the trial * Lack of ability to cooperate

Design outcomes

Primary

MeasureTime frameDescription
Conditioned Pain ModulationDay 0 (Pre) to Day 3 (Post) in each stimulation phaseChange in cuff pain threshold with contralateral cuff conditioning stimulus

Secondary

MeasureTime frameDescription
Temporal Summation of PainDay 1 (Pre) to Day 3 (Post) in each stimulation phaseChange in pain intensity ratings (i.e. on an electronic Visual Analogue Scale from 0=no pain to 10=worst pain imaginable) across series of 10 x 1s cuff stimuli at 0.5Hz (scores are normalized to first rating by subtraction and grouped into 3 epochs of 3 inflations with higher change scores indicating higher summation/facilitation)
Pressure Pain ThresholdsDay 1 (Pre) to Day 3 (Post) in each stimulation phaseHandheld algometry over the extensor carpi radialis, upper trapezius, lower back and gastrocnemius muscles
Pain IntensityDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseVisual Analogue Scale from 0=no pain to 10=worst pain imaginable currently at rest and with worst movement, as well as maximum in past week
Pain UnpleasantnessDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseVisual Analogue Scale from 0=not unpleasant at all to 10=most unpleasant sensation imaginable currently at rest and with worst movement, as well as maximum in past week
Roland-Morris Disability QuestionnaireDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseMeasures back-related disability for 24 statements of potentially afflicted tasks with dichotomous responses. Minimum 0 to maximum 24 with higher scores indicating worse disability.
Back Performance ScaleDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phase5 Task scale rated as per performance as a functional measure of back-related disability (each task is rated on a 4 point Likert scale 0-3 and summed to give total), scored from 0-15 with higher scores indicating more pain and dysfunction during task performance. Here will be used to characterize functional disability.
Pain AreaDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseTotal number of pixels coloured on an electronic body chart (Navigate Pain)

Other

MeasureTime frameDescription
Flanker Task LearningDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseReaction time to selective attention based computer task
Affect ManipulationDay 0 (Pre) to Day 3 (Post) and 2 weeks post for each stimulation phaseEffect of image watching on ratings of mood and arousal. Mood and arousal will be measured with the Self Assessment Manikin - a 9 point Likert-type scale with 1 representing most negative/most calm, 5 as neutral, and 9 as most positive/most aroused.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026